Navigation Links
Improving equine health: Research studies vaccinations to protect newborn foals
Date:4/4/2012

MANHATTAN, KAN. -- A Kansas State University veterinary medicine student is investigating ways to improve horse vaccinations and defend them against pathogen challenges at an early age.

Research from Allison Jordan Bryan, a graduate student in biomedical sciences and a second-year veterinary medicine student, Huntington Beach, Calif., may help protect foals as young as 3 months of age from pathogens such as West Nile virus, tetanus, equine influenza virus, Equine Herpes Virus-1, Eastern equine encephalomyelitis and Western equine encephalomyelitis.

"It is important, especially in the equine world, to vaccinate the foals as soon as possible so they will be protected against environmental pathogens they may come into contact with, even at an early age," Bryan said.

Bryan recently received a second place award at the K-State Research Forum for her oral research presentation titled "Characterization of immune activation in healthy foals when vaccination is initiated at 3 months of age."

Foals acquire maternal antibodies and immune cells that help protect them from environmental pathogens before they can fully develop their own immune systems, Bryan said. Newborn foals acquire these maternal antibodies and cells through ingestion and absorption of colostrum.

Foals are usually vaccinated at 6 months of age, which gives time for maternal antibodies to decline so they do not interfere with any vaccines. But Bryan is looking at the possibility of vaccinating foals at 3 months of age -- the earlier age is better because it gives foals more protection against pathogens earlier in life.

"We're trying to determine whether those maternal antibodies are still in high enough concentration at 3 months to interfere with vaccines and block the active immune response or to see if these antibodies have waned enough to allow a robust immune response," Bryan said.

Bryan is still collecting and analyzing data. Preliminary data has indicated an immune response in 3-month-old foals, making it possible to vaccinate foals at a younger age and increase protection.

Although Bryan has always been interested in the immune system, she got involved with equine research after spending a summer in the university's Veterinary Research Scholars Program, which is funded by the National Institutes of Health, or NIH, and Merial, a worldwide animal health company.

Bryan is now participating in the NIH-funded Basic Research Immersion Training Experience, or BRITE, program. Her faculty advisers are Elizabeth Davis, associate professor of clinical sciences, and Melinda Wilkerson, professor of diagnostic medicine and pathobiology.

"Jordan is a talented individual who has a very bright future in the field of biomedical research," Davis said. "In the past year she has gained knowledge and skills that will help her with her future investigative endeavors. It has been a pleasure to have her as a graduate student in our program."

"The mentorship and guidance has made it a wonderful experience and I will definitely pursue a career in research following completion of my veterinary degree," Bryan said. "I have been very fortunate to work with extremely talented individuals at K-State and am honored to be a part of the research community here at K-State."


'/>"/>

Contact: Allison Jordan Bryan
ajbryan@k-state.edu
Kansas State University
Source:Eurekalert

Related biology news :

1. High blood sugars impact on immune system holds clues to improving islet cell transplants
2. Greatest thing since sliced bread: New data offer important clues toward improving wheat yields
3. Improving livestock productivity in Honduras
4. Improving the odds
5. New patented technology for improving cardiac CTs receives NIH support
6. Improving the degradation of toxic hydrocarbons
7. Lengthening time a drug remains bound to a target may lead to improving diagnostics, therapy
8. Inventor honored for tech improving access to clean water, healthcare, and business development in India
9. Algae advances as a green alternative for improving water quality
10. Improving clinical use of stem cells to repair heart damage
11. A new tool for improving switchgrass
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® test, ... clinically significant acute bacterial and viral respiratory tract infections by testing the ...
(Date:10/11/2017)... YORBA LINDA, CA (PRWEB) , ... October 11, ... ... adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and ... activation (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology: